The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
This achievement exemplifies the impact of data-driven, collaborative science in addressing complex clinical challenges. It sets a new benchmark for endpoint innovation, not only in transplantation, but across clinical research more broadly.
#ClinicalResearch #Innovation #PoweredByESOT
We are pleased to announce that the following ESOT Sections and Committees launched a call for nominations for new Board members: EKITA, ELITA, VCA, BSC, YPT
YPT – The Young Professionals in Transplantation Committee – would like to announce a call for nominations for two Board members. The new YPT Board Members will hold office for four years (2026–2030), starting in September 2026.
The release of the 2024 Report of the Global Observatory on Donation and Transplantation (GODT), which has been managed by the Organización Nacional de Trasplantes (ONT) as collaborating centre of the World Health Organization (WHO) in the field of transplantation, presents the latest official data on organ donation and transplantation worldwide. Based on submissions from
As we come to the close of the year, we take a moment to reflect not only on what we have achieved but on how we have moved forward together. In transplantation, resilience comes not from pushing harder, but from listening more carefully. It emerges when the full breadth of the transplantation community feels heard, particularly those
The European Society for Organ Transplantation (ESOT) reaffirms its mission to protect patients living with, or in need of, life-sustaining therapies for end-stage organ disease, and to uphold the ethical foundations of medical care, regardless of geography, nationality, or political context.
The European Society for Organ Transplantation (ESOT) is pleased to announce that applications are now open for the HESPERIS Course 2026, which will take place from 16 to 18 April 2026 in Rotterdam. The HESPERIS Course is a comprehensive and immersive educational programme designed for physicians, surgeons, and scientists entering the field of organ transplantation.
The presence of anti-human leukocyte antigen (anti-HLA) antibodies defines transplant candidates as sensitised, a condition that affects access to transplantation, increasing waiting times and mortality rates. Following transplantation, sensitised patients have higher risk of antibody-mediated rejection (AMR) and graft failure when their anti-HLA antibodies are specific to the donor (DSA). Not all DSAs are equally
Are you passionate about visual storytelling, public art, or social causes? Here’s a rare opportunity to showcase your talent and celebrate something truly life-changing—organ donation. Enter the ‘Be A LonDonor’ Design Competition, a creative call to honour donor families and celebrate the second chances organ recipients receive. What’s in it for you? £1,000 cash prize
The European Society for Organ Transplantation (ESOT), in partnership with The Lancet, has launched the ESOT–Lancet Commission on Transplantation, a global initiative to reimagine transplantation as a cornerstone of sustainable and equitable healthcare. Led by Elmi Müller and Gabriel Oniscu (ESOT Past President), the Commission brings together international experts to develop a roadmap for integrating
